Weight loss injections promise quick results, but skipping blood screening can trigger serious risks like pancreatitis or ...

CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...

By Elizabeth Shockman, MPR News acing a massive increase in employee health insurance rates, leaders at Anoka-Hennepin Area Schools last May asked a question out loud: Should the district stop paying ...

Laura Schmidt and colleagues identify systemic financial conflicts of interest that serve as a cautionary tale for users of medical guidelines Prescribing glucagon-like peptide 1 (GLP-1) receptor ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

Eli Lilly is a leader in the weight loss drug market, generating blockbuster revenue. Viking Therapeutics recently launched a phase 3 trial for its weight loss candidate -- and could have a promising ...

The two largest health insurers in Massachusetts are effectively telling the drug companies that they may seek a rapidly ...

Insurers are cutting coverage, citing costs. But there’s seldom any discussion of the return on investment from these drugs ...

Getting into the exercise habit was also important since one day, most people on Ozempic or Wegovy will stop taking it - putting themselves at risk of putting the weight back on if they were not ...

A WOMAN has shared the grim side effect from Mounjaro that’s so bad she’s thinking of stopping the drug altogether. Kelly, ...